This website was discontinued on 20/12/2022. Visit the new website at www.fct.pt.
The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.
Functional, molecular and pharmacological studies of p53 family proteins: from yeast to human cells. Lucília Helena Ataíde Saraiva, Instituto de Ciências e Tecnologias Agrárias e Agro-Alimentares - Porto (ICETA-Porto/ICETA). €168,200.
Developing strategies to understand antibiotics influx at a molecular level. Alberta Paula Lobo Machado Gameiro-dos-Santos, Instituto de Ciências e Tecnologias Agrárias e Agro-Alimentares - Porto (ICETA-Porto/ICETA). €159,800.
InVitroBrain - Development of a humanized dynamic in vitro blood-brain barrier model and a vesicle-based barrier for brain penetration of drugs incorporated in lipid nanoparticles - Closing the gap between in vivo and in vitro properties. Domingos de Carvalho Ferreira, Faculdade de Farmácia da Universidade do Porto (FF/UP). €115,441.
NanoLaseRelief: Integrando nanotecnologias no alívio da dor na terapia laser de lesões vasculares. Eliana Souto, Fundação Ensino e Cultura Fernando Pessoa (FECFP). €168,000.
TARGETING HEMOZOIN CRYSTAL STRUCTURE: A RATIONAL APPROACH TO THE DESIGN OF NOVEL ANTIMALARIALS. Maria Alexandra da Silva Paulo, Faculdade de Farmácia da Universidade de Lisboa (FF/ULisboa). €106,868.
Development of a mucosal hepatitis B vaccine: Design and mechanistic studies of a prototypic multi-component polymeric delivery system. Olga Maria Fernandes Borges, Centro de Neurociências e Biologia Celular (CNBC/UC). €122,060.
Development and pre-clinical evaluation of a new HIV-1 vaccine concept. Nuno Eduardo Moura dos Santos da Costa Taveira, Associação para o Desenvolvimento do Ensino e Investigação da Microbiologia (ADEIM). €168,200.
Albumin binding-domain fusions to improve protein pharmacokinetics. Joao Goncalves, Associação para o Desenvolvimento do Ensino e Investigação da Microbiologia (ADEIM). €147,900.